Literature DB >> 30684646

First report of New Delhi metallo-β-lactamase-6 (NDM-6) among Klebsiella pneumoniae ST147 strains isolated from dialysis patients in Iran.

Aghil Bahramian1, Aref Shariati1, Taher Azimi2, Javad Yasbolaghi Sharahi1, Narjess Bostanghadiri1, Latif Gachkar3, Zohreh Ghalavand1, Alireza Salimi Chirani1, Soroor Erfanimanesh4, Ali Hashemi5.   

Abstract

There has been an alarming health-related concern about the growth of New Delhi metallo-β-lactamase. The aims of this study include the phenotypic detection of β-lactamases and molecular characterization of NDM in Klebsiella pneumoniae isolates in Tehran, Iran. A total of 120 K. pneumoniae isolates were collected from hospitalized haemodialysis patients, Tehran, Iran from March 2014 to February 2017. Antibiotic susceptibility tests were conducted using Kirby-Bauer disc diffusion and Broth Microdilution methods according to Clinical and Laboratory Standards Institute guidelines. Metallo-β-lactamase was detected using the Combined Disc Diffusion Test (CDDT), and production of carbapenemase was screened using the Modified Hodge Test. NDM-producing K. pneumoniae strains were screened for the presence of mcr-1 gene, β-lactamase genes, and 16S rRNA methylase genes by Polymerase Chain Reaction and sequencing. Molecular typing of the strains was determined using Repetitive Sequence Based-PCR and Multilocus Sequence Typing. The blaNDM-6 gene was detected in 3 (2.5%) out of 120 isolates from dialysis patients. Also, the three isolates were positive for blaCTX-M-15,blaTEM extended-spectrum β-lactamase genes, armA type plasmid-mediated 16S rRNA methylase and CMY-type plasmid-mediated AmpC β-lactamase. The isolates were identified as MLST sequence type 147 (ST147). This is the first report of blaNDM-6 in K. pneumoniae strains, isolated in Iran.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Carbapenemase; Klebsiella pneumoniae; New Delhi metallo- β-lactamase-6

Mesh:

Substances:

Year:  2019        PMID: 30684646     DOI: 10.1016/j.meegid.2019.01.030

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  10 in total

1.  Phenotypic and molecular characterization of extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Klebsiella pneumoniae in Iran.

Authors:  Forough Babazadeh; Roghayeh Teimourpour; Mohsen Arzanlou; Hadi Peeridogaheh; Mehdi Yousefipour; Jafar MohammadShahi
Journal:  Mol Biol Rep       Date:  2022-06-03       Impact factor: 2.742

2.  Emergence of a Carbapenem-Resistant Klebsiella pneumoniae Isolate Co-harbouring Dual bla NDM- 6 -Carrying Plasmids in China.

Authors:  Yali Gong; Yifei Lu; Dongdong Xue; Yu Wei; Qimeng Li; Gang Li; Shuguang Lu; Jing Wang; Yunying Wang; Yizhi Peng; Yan Zhao
Journal:  Front Microbiol       Date:  2022-05-18       Impact factor: 6.064

3.  Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children's Hospital, Tehran, Iran: 2013-2018.

Authors:  Taher Azimi; Saied Maham; Fatemeh Fallah; Leila Azimi; Zari Gholinejad
Journal:  Infect Drug Resist       Date:  2019-07-17       Impact factor: 4.003

4.  Evaluation of Nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from burn wound infection in Tehran, Iran.

Authors:  Aref Shariati; Elham Asadian; Fatemeh Fallah; Taher Azimi; Ali Hashemi; Javad Yasbolaghi Sharahi; Majid Taati Moghadam
Journal:  Infect Drug Resist       Date:  2019-07-23       Impact factor: 4.003

Review 5.  How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.

Authors:  Majid Taati Moghadam; Nour Amirmozafari; Aref Shariati; Masoumeh Hallajzadeh; Shiva Mirkalantari; Amin Khoshbayan; Faramarz Masjedian Jazi
Journal:  Infect Drug Resist       Date:  2020-01-07       Impact factor: 4.003

6.  In vitro antibacterial activity of curcumin-meropenem combination against extensively drug-resistant (XDR) bacteria isolated from burn wound infections.

Authors:  Javad Yasbolaghi Sharahi; Zahra Aliakbar Ahovan; Donya Taghizadeh Maleki; Zahra Riahi Rad; Zohreh Riahi Rad; Mehdi Goudarzi; Aref Shariati; Narjess Bostanghadiri; Elham Abbasi; Ali Hashemi
Journal:  Avicenna J Phytomed       Date:  2020 Jan-Feb

Review 7.  Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.

Authors:  Zahra Chegini; Amin Khoshbayan; Soheil Vesal; Alireza Moradabadi; Ali Hashemi; Aref Shariati
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-04-26       Impact factor: 3.944

8.  Wastewaters, with or without Hospital Contribution, Harbour MDR, Carbapenemase-Producing, but Not Hypervirulent Klebsiella pneumoniae.

Authors:  Adela Teban-Man; Anca Farkas; Andreea Baricz; Adriana Hegedus; Edina Szekeres; Marcel Pârvu; Cristian Coman
Journal:  Antibiotics (Basel)       Date:  2021-03-29

9.  Evaluation of phenotypic and genotypic patterns of aminoglycoside resistance in the Gram-negative bacteria isolates collected from pediatric and general hospitals.

Authors:  Leila Azimi; Shahnaz Armin; Hossein Samadi Kafil; Nafiseh Abdollahi; Kiarash Ghazvini; Sepide Hasanzadeh; Shahram Shahraki Zahedani; Sedigheh Rafiei Tabatabaei; Fatemeh Fallah
Journal:  Mol Cell Pediatr       Date:  2022-02-04

10.  Post-antibiotic era in hemodialysis? Two case reports of simultaneous colonization and bacteremia by multidrug-resistant bacteria.

Authors:  Johanna M Vanegas; Lorena Salazar-Ospina; Gustavo A Roncancio; Julián Builes; Judy Natalia Jiménez
Journal:  J Bras Nefrol       Date:  2021 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.